)

Fortress Biotech (FBIO) investor relations material
Fortress Biotech Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Q2 2025 net revenue was $16.4M, up 10% year-over-year, mainly from Journey's dermatology products and $1.4M from Avenue's license termination with AnnJi.
Emrosi launched in March 2025, contributing $2.8M in Q2 revenue, with strong initial prescription ramp and expanded payer coverage announced in July 2025.
Q2 2025 net income attributable to common stockholders was $13.4M, compared to a net loss of $13.3M in Q2 2024, driven by a $27.1M gain from the deconsolidation of Checkpoint after its sale to Sun Pharma.
Joined the Russell 2000® and Russell 3000® Indexes in June 2025, reflecting increased market visibility.
The company paused dividends on Series A Preferred Stock, accumulating $8.0M in undeclared dividends as of June 30, 2025.
Financial highlights
Q2 2025 net revenue: $16.4M (up 10% year-over-year); six months ended June 30, 2025: $29.6M (up 6%).
Q2 2025 net income attributable to common stockholders: $13.4M; EPS (diluted): $0.45 vs. $(0.73) in Q2 2024.
Q2 2025 operating loss: $(36.5)M, up from $(27.8)M in Q2 2024, due to higher SG&A and stock-based compensation.
Gross margin improved to 67% from 61% year-over-year, driven by favorable product mix and Emrosi sales.
Cash and cash equivalents at June 30, 2025: $74.4M; restricted cash: $1.2M.
Outlook and guidance
Management anticipates continued growth and operating leverage in H2 2025, supported by Emrosi's market traction and expanding payer access.
Current cash and equivalents are expected to fund operations for at least the next 12 months; additional funding may be needed for R&D, regulatory filings, and commercialization.
The company will seek further capital through equity, debt, or asset sales as needed to support development and expansion.
Next Fortress Biotech earnings date

Next Fortress Biotech earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage